ZA98221B - Amylin agonist pharmaceutical compositions containing insulin - Google Patents
Amylin agonist pharmaceutical compositions containing insulinInfo
- Publication number
- ZA98221B ZA98221B ZA98221A ZA98221A ZA98221B ZA 98221 B ZA98221 B ZA 98221B ZA 98221 A ZA98221 A ZA 98221A ZA 98221 A ZA98221 A ZA 98221A ZA 98221 B ZA98221 B ZA 98221B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- amylin agonist
- containing insulin
- agonist pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/000662 WO1999034764A2 (fr) | 1998-01-09 | 1998-01-09 | Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline |
| ZA98221A ZA98221B (en) | 1998-01-09 | 1998-01-12 | Amylin agonist pharmaceutical compositions containing insulin |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/000662 WO1999034764A2 (fr) | 1998-01-09 | 1998-01-09 | Compositions pharmaceutiques a agoniste d'amyline, contenant de l'insuline |
| ZA98221A ZA98221B (en) | 1998-01-09 | 1998-01-12 | Amylin agonist pharmaceutical compositions containing insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA98221B true ZA98221B (en) | 1998-11-25 |
Family
ID=26793877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA98221A ZA98221B (en) | 1998-01-09 | 1998-01-12 | Amylin agonist pharmaceutical compositions containing insulin |
Country Status (2)
| Country | Link |
|---|---|
| WO (1) | WO1999034764A2 (fr) |
| ZA (1) | ZA98221B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007104786A1 (fr) * | 2006-03-15 | 2007-09-20 | Novo Nordisk A/S | Melanges d'amyline et d'insuline |
| EP2200635A1 (fr) * | 2007-09-11 | 2010-06-30 | Novo Nordisk A/S | Mélange comprenant de l'amyline, qui est un peptide, et une insuline retard |
| EP2036539A1 (fr) * | 2007-09-11 | 2009-03-18 | Novo Nordisk A/S | Formulations stables d'amyline et ses analogues |
| AR103954A1 (es) | 2015-03-18 | 2017-06-14 | Zealand Pharma As | Análogos de amilina |
| TWI784968B (zh) * | 2016-09-09 | 2022-12-01 | 丹麥商西蘭製藥公司 | 澱粉素類似物 |
| EP3474820B1 (fr) | 2017-08-24 | 2024-02-07 | Novo Nordisk A/S | Compositions glp-1 et ses utilisations |
| PE20230819A1 (es) | 2020-02-18 | 2023-05-19 | Novo Nordisk As | Composiciones y usos de glp-1 |
-
1998
- 1998-01-09 WO PCT/US1998/000662 patent/WO1999034764A2/fr not_active Ceased
- 1998-01-12 ZA ZA98221A patent/ZA98221B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999034764A2 (fr) | 1999-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100867A3 (en) | Pharmaceutical compositions containing celecoxib | |
| HUP0201545A3 (en) | Betha2-adrenergic receptor agonists and pharmaceutical compositions containing them | |
| HU9901606D0 (en) | Pharmaceutical compositions | |
| HUP0102483A3 (en) | Pharmaceutical compositions containing androst-5-ene-3betha,17betha-diol | |
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| IL132029A0 (en) | Pharmaceutical compositions containing di-aryl ethers | |
| HUP0103507A3 (en) | Pharmaceutical compositions comprising 2-quinolones | |
| IL134901A0 (en) | Insoluble insulin compositions | |
| GB9827996D0 (en) | Pharmaceutical Compositions | |
| IL139479A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| HU9701945D0 (en) | Pharmaceutical composition for injection containing cyclodextrin | |
| AU4413299A (en) | Stabilized pharmaceutical compositions | |
| AU1574900A (en) | Pharmaceutical compositions containing insulin | |
| HUP0104452A3 (en) | Medicinal compositions, containing tricyclo compounds | |
| PT1466615E (pt) | Composição farmacêutica | |
| HUP0104657A3 (en) | Imidazole compounds and pharmaceutical compositions containing them | |
| HU9802795D0 (en) | Pharmaceutical compositions containing more active components | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| IL123143A0 (en) | Pharmaceutical compositions containing mupirocin | |
| IL141876A0 (en) | A pharmaceutical composition containing fetuin | |
| IL137505A0 (en) | Pharmaceutical compositions containing tramadol | |
| GB9809213D0 (en) | Pharmaceutical compositions | |
| HUP0200747A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| IL142534A0 (en) | Pharmaceutical compositions containing an antigen-adjuvent | |
| AU6370299A (en) | Pharmaceutical compositions containing tetrahydroisoquinoline compounds |